213 related articles for article (PubMed ID: 9608583)
1. Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: correlation with repair.
McIntosh L; Granberg KE; Brière KM; Anderson JE
NMR Biomed; 1998 Feb; 11(1):1-10. PubMed ID: 9608583
[TBL] [Abstract][Full Text] [Related]
2. Deflazacort but not prednisone improves both muscle repair and fiber growth in diaphragm and limb muscle in vivo in the mdx dystrophic mouse.
Anderson JE; McIntosh LM; Poettcker R
Muscle Nerve; 1996 Dec; 19(12):1576-85. PubMed ID: 8941272
[TBL] [Abstract][Full Text] [Related]
3. Regeneration and myogenic cell proliferation correlate with taurine levels in dystrophin- and MyoD-deficient muscles.
McIntosh LM; Garrett KL; Megeney L; Rudnicki MA; Anderson JE
Anat Rec; 1998 Oct; 252(2):311-24. PubMed ID: 9776086
[TBL] [Abstract][Full Text] [Related]
4. Deflazacort increases laminin expression and myogenic repair, and induces early persistent functional gain in mdx mouse muscular dystrophy.
Anderson JE; Weber M; Vargas C
Cell Transplant; 2000; 9(4):551-64. PubMed ID: 11038071
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of regulatory RNAs, including lncRNAs and tRNAs, during postnatal growth of normal and dystrophic (mdx) mouse muscles, and their response to taurine treatment.
Butchart LC; Terrill JR; Rossetti G; White R; Filipovska A; Grounds MD
Int J Biochem Cell Biol; 2018 Jun; 99():52-63. PubMed ID: 29578051
[TBL] [Abstract][Full Text] [Related]
6. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.
De Luca A; Pierno S; Liantonio A; Cetrone M; Camerino C; Fraysse B; Mirabella M; Servidei S; Rüegg UT; Conte Camerino D
J Pharmacol Exp Ther; 2003 Jan; 304(1):453-63. PubMed ID: 12490622
[TBL] [Abstract][Full Text] [Related]
7. Correlated NOS-Imu and myf5 expression by satellite cells in mdx mouse muscle regeneration during NOS manipulation and deflazacort treatment.
Anderson JE; Vargas C
Neuromuscul Disord; 2003 Jun; 13(5):388-96. PubMed ID: 12798794
[TBL] [Abstract][Full Text] [Related]
8. Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy.
Whitehead NP; Bible KL; Kim MJ; Odom GL; Adams ME; Froehner SC
J Physiol; 2016 Dec; 594(24):7215-7227. PubMed ID: 27570057
[TBL] [Abstract][Full Text] [Related]
9. Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse.
Gibertini S; Zanotti S; Savadori P; Curcio M; Saredi S; Salerno F; Andreetta F; Bernasconi P; Mantegazza R; Mora M
Cell Tissue Res; 2014 May; 356(2):427-43. PubMed ID: 24723230
[TBL] [Abstract][Full Text] [Related]
10. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
11. Dystrophy and myogenesis in mdx diaphragm muscle.
Anderson JE; Garrett K; Moor A; McIntosh L; Penner K
Muscle Nerve; 1998 Sep; 21(9):1153-65. PubMed ID: 9703441
[TBL] [Abstract][Full Text] [Related]
12. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
13. Myotonic ADR-MDX mutant mice show less severe muscular dystrophy than MDX mice.
Krämer R; Lochmüller H; Abicht A; Rüdel R; Brinkmeier H
Neuromuscul Disord; 1998 Dec; 8(8):542-50. PubMed ID: 10093060
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive MRI and spectroscopy of mdx mice reveal temporal changes in dystrophic muscle imaging and in energy deficits.
Heier CR; Guerron AD; Korotcov A; Lin S; Gordish-Dressman H; Fricke S; Sze RW; Hoffman EP; Wang P; Nagaraju K
PLoS One; 2014; 9(11):e112477. PubMed ID: 25390038
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy.
Cozzoli A; Rolland JF; Capogrosso RF; Sblendorio VT; Longo V; Simonetti S; Nico B; De Luca A
Neuropathol Appl Neurobiol; 2011 Apr; 37(3):243-56. PubMed ID: 20618838
[TBL] [Abstract][Full Text] [Related]
16. Metabolic profile of dystrophic mdx mouse muscles analyzed with in vitro magnetic resonance spectroscopy (MRS).
Martins-Bach AB; Bloise AC; Vainzof M; Rahnamaye Rabbani S
Magn Reson Imaging; 2012 Oct; 30(8):1167-76. PubMed ID: 22673895
[TBL] [Abstract][Full Text] [Related]
17. The effects of altered metabolism (hypothyroidism) on muscle repair in the mdx dystrophic mouse.
McIntosh LM; Pernitsky AN; Anderson JE
Muscle Nerve; 1994 Apr; 17(4):444-53. PubMed ID: 8170492
[TBL] [Abstract][Full Text] [Related]
18. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
[TBL] [Abstract][Full Text] [Related]
19. Regeneration-blocked mdx muscle: in vivo model for testing treatments.
Quinlan JG; Cambier D; Lyden S; Dalvi A; Upputuri RK; Gartside P; Michaels SE; Denman D
Muscle Nerve; 1997 Aug; 20(8):1016-23. PubMed ID: 9236793
[TBL] [Abstract][Full Text] [Related]
20. Metabolic shifts and myocyte hypertrophy in deflazacort treatment of mdx mouse cardiomyopathy.
Skrabek RQ; Anderson JE
Muscle Nerve; 2001 Feb; 24(2):192-202. PubMed ID: 11180202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]